Currently in development, our drug would reduce damage to heart during a heart attack and brain during a stroke - no approved drug is capable of doing this.
We are a Wisconsin LLC organized to commercialize intellectual property assigned to the LLC. The IP relates to a drug which has been shown to reduce the damage caused to the heart by 30% during a heart attack. It also appears to reduce damage to the brain during a stroke. The IP is protected by two issued U.S. patents with a third pending.